BGM
ACET icon

Burkehill Global Management’s Adicet Bio ACET Stock Holding History

Burkehill Global Management’s Portfolio ACET Stock Details ACET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$426K Hold
62,500
– – 0.02% 175
2025
Q4 		$526K Buy
+62,500
New +$691K 0.03% 157

Other funds holding ACET

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Burkehill Global Management's ACET Position: Q1 2026 in Review

Burkehill Global Management held its Adicet Bio (ACET) position steady in Q1 2026 at 62,500 shares worth $426K. The position accounts for 0.02% of the portfolio, ranked #175.

Burkehill Global Management first reported a position in ACET in Q4 2025 and has held it in 2 quarters since. The position peaked at $526K in Q4 2025. 49 funds tracked by Wall St. Rank hold ACET as of Q1 2026.

  • Burkehill Global Management held 62,500 shares of Adicet Bio worth $426K as of Q1 2026.
  • Burkehill Global Management left its Adicet Bio share count unchanged in Q1 2026.
  • Adicet Bio made up 0.02% of Burkehill Global Management's portfolio in Q1 2026, its #175 holding.
  • Burkehill Global Management first reported a position in Adicet Bio in Q4 2025 and has held it in 2 quarters since.
  • Burkehill Global Management's Adicet Bio position peaked at $526K in Q4 2025.
  • 49 funds tracked by Wall St. Rank held Adicet Bio as of Q1 2026.

Based on Burkehill Global Management's 13F filing for Q1 2026, filed 15 May 2026.